Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Finch Therapeutics Group Inc
FNCHCurrent price
11.8 USD
+0.3 USD (+2.61%)
Last closed
11.95 USD
Company
www.finchtherapeutics.com
ISIN
US31773D1019
Sector
Healthcare
Industry
Biotechnology
Exchange
PINK
Capitalization
18 947 968 USD
Yield for 12 month
+210.94 %
1Y
3Y
5Y
10Y
15Y
FNCH
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company develops FIN-211, a microbiome candidate designed to address the gastrointestinal and behavioral symptoms of autism spectrum disorder; and FIN-524 for the prevention, diagnosis, theragnosis or treatment of diseases in humans, including ulcerative colitis; FIN-525 for the treatment of Crohn's disease; and other microbiome product candidates. The company has collaboration and license agreements with Takeda Pharmaceutical Company Limited; and license agreements with Skysong Innovations LLC, OpenBiome, Arizona State University, and University of Minnesota. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Boston, Massachusetts. Address: 75 State Street, Boston, MA, United States, 02109
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
90 USDP/E ratio
–Dividend Yield
–Current Year
+107 000 USD
Last Year
+861 000 USD
Current Quarter
–
Last Quarter
+2 845 000 USD
Current Year
-1 413 000 USD
Last Year
-4 646 000 USD
Current Quarter
–
Last Quarter
-43 000 USD
Key Figures FNCH
1 year
3 years
5 years
10 years
EBITDA
-19 506 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-21.89 %
PEG Ratio
–
Return On Equity TTM
-67.28 %
Wall Street Target Price
90 USD
Revenue TTM
–
Book Value
8.86 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
-57 032 000 USD
Earnings per share
-8.8 USD
Diluted Eps TTM
-8.8 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics FNCH
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History FNCH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:30
Payout Ratio
–
Last Split Date
12.06.2023
Dividend Date
–
Stock Valuation FNCH
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
77.2121
Price Sales TTM
30.4644
Enterprise Value EBITDA
0.1677
Price Book MRQ
1.3326
Financials FNCH
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators FNCH
For 52 weeks
0.8 USD
14.26 USD
50 Day MA
11.84 USD
Shares Short Prior Month
26 349
200 Day MA
5.22 USD
Short Ratio
0.19
Shares Short
19 195
Short Percent
2.76 %
BeatStart